Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97738067 | 9773806 | 7 | F | 20131129 | 20160921 | 20131220 | 20160926 | EXP | CA-ROCHE-1322171 | ROCHE | 74.05 | YR | F | Y | 0.00000 | 20160926 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97738067 | 9773806 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 375 | MG | SOLUTION FOR INJECTION | Q3W | ||||||
| 97738067 | 9773806 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 97738067 | 9773806 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 97738067 | 9773806 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 97738067 | 9773806 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 97738067 | 9773806 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 97738067 | 9773806 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 97738067 | 9773806 | 8 | C | OXEZE | 2 | Unknown | UNK | U | 0 | ||||||||||
| 97738067 | 9773806 | 9 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 1 COURSE OF PREDNSIONE | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97738067 | 9773806 | 1 | Asthma |
| 97738067 | 9773806 | 6 | Product used for unknown indication |
| 97738067 | 9773806 | 7 | Product used for unknown indication |
| 97738067 | 9773806 | 8 | Product used for unknown indication |
| 97738067 | 9773806 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97738067 | 9773806 | HO |
| 97738067 | 9773806 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97738067 | 9773806 | Asthenia | |
| 97738067 | 9773806 | Cough | |
| 97738067 | 9773806 | Diabetes mellitus | |
| 97738067 | 9773806 | Eye pruritus | |
| 97738067 | 9773806 | Fatigue | |
| 97738067 | 9773806 | Hypersensitivity | |
| 97738067 | 9773806 | Pulmonary oedema | |
| 97738067 | 9773806 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 97738067 | 9773806 | 1 | 20110203 | 0 | ||
| 97738067 | 9773806 | 5 | 20160822 | 0 |